BAP1 and cancer: Lifetime cancer risks for individuals with a BAP1 GPV (henceforth referred to as BAP1 carriers) are reported to be 20–25% for mesothelioma, uveal and cutaneous melanoma, with lower lifetime risks reported for renal cell carcinoma and other associated cancers.